C3 activation is inhibited by analogs of compstatin but not by serine protease inhibitors or peptidyl α-ketoheterocycles

This publication has 41 references indexed in Scilit:

• Structure of 3,4-Dichloroisocoumarin-Inhibited Factor D
  Acta Crystallographica Section D-Biological Crystallography, 1998
• A new microcellular cytotoxicity test based on calcein AM release
  Human Immunology, 1993
• Novel inhibitors of human renin. Cyclic peptides based on the tetrapeptide sequence Glu-D-Phe-Lys-D-Trp
  Journal of Medicinal Chemistry, 1990
• Proteolytic activity of the different fragments of factor B on the third component of complement (C3). Involvement of the N-terminal domain of Bb in magnesium binding
  Molecular Immunology, 1990
• Effects of D-amino acid substitution on antagonist activities of angiotensin II analogs
  Journal of Medicinal Chemistry, 1988
• Biologically active analogs of thymopentin with enhanced enzymatic stability
  Peptides, 1986
• INITIATION OF THE ALTERNATIVE COMPLEMENT PATHWAY DUE TO SPONTANEOUS HYDROLYSIS OF THE THIOESTER OF C3^a
  Annals of the New York Academy of Sciences, 1983
• An improved fluorogenic substrate for the alternative complement pathway C3/5 converting enzyme CVFBb
  Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1983
• Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3.
  The Journal of Experimental Medicine, 1981
• EVALUATION OF THE TRYPAN BLUE TECHNIQUE FOR DETERMINATION OF CELL VIABILITY
  Transplantation, 1964